Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock - $0.001 par value
-
Shares outstanding
-
10,630,964
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
5,231,367
-
Shares change
-
-50,928
-
Total reported value, excl. options
-
$34,791,000
-
Value change
-
-$660,885
-
Number of buys
-
11
-
Number of sells
-
-3
-
Price
-
$6.65
Significant Holders of NEPHROS INC - Common Stock - $0.001 par value (NEPH) as of Q1 2021
18 filings reported holding NEPH - NEPHROS INC - Common Stock - $0.001 par value as of Q1 2021.
NEPHROS INC - Common Stock - $0.001 par value (NEPH) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,231,367 shares
of 10,630,964 outstanding shares and own 49.21% of the company stock.
Largest 10 shareholders include WEXFORD CAPITAL LP (3,564,530 shares), Cowen Prime Services LLC (622,750 shares), Samjo Capital LLC (550,000 shares), BARD ASSOCIATES INC (219,378 shares), VANGUARD GROUP INC (96,195 shares), HighTower Advisors, LLC (55,710 shares), BLAIR WILLIAM & CO/IL (36,249 shares), BlackRock Inc. (23,559 shares), MILLENNIUM MANAGEMENT LLC (18,909 shares), and CITADEL ADVISORS LLC (18,421 shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.